Monograph Details
|
|
Gastrointestinal Tract
> Nausea
|
|
ALOXI CAPSULES |
| Manufacturer |
|
Eisai Pharmaceuticals |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Selective 5-HT3 receptor antagonist. |
| Generic Name |
|
Palonosetron (as HCl) 0.5mg; caps. |
| Also |
|
• ALOXI
|
| Indications |
|
Prevention of acute nausea and vomiting due to initial and repeat courses of moderately emetogenic chemotherapy. |
| Children |
|
<18yrs: not recommended. |
| Adults |
|
≥18yrs: 0.5mg one hour prior to chemotherapy. |
| Precautions |
|
Pregnancy (Cat.B). Labor & delivery. Nursing mothers: not recommended. |
| Adverse Reactions |
|
Headache, constipation, fatigue, GI disturbances, dizziness, tachycardia, bradycardia, hypotension, QT prolongation. |
| How Supplied |
Single-use vial (0.075mg/1.5mL)—5
(0.25mg/5mL)—1
Caps—5 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
